Depixus Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 63

Employees

  • Latest Deal Type
  • Series B
  • (Upcoming)

  • Investors
  • 7

Depixus General Information

Description

Developer of a novel technology intended to offer real-time analysis of individual biomolecular interactions at a massive scale. The company's technology has wide-ranging applications and specializes in a genomic region to be analyzed swiftly and easily on a single integrated platform with the investigator to specify the level of sequence and epigenetic detail required, enabling researchers to reveal new biological pathways, decode disease mechanisms, and unlock routes to develop new precision medicines.

Contact Information

Website
www.depixus.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3-5 Impasse Reille
  • 75014 Paris
  • France
+33 09
Primary Industry
Electronic Equipment and Instruments
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
LOHAS & Wellness
Corporate Office
  • 3-5 Impasse Reille
  • 75014 Paris
  • France
+33 09

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Depixus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) Upcoming Product Development
4. Later Stage VC (Series A) 02-Dec-2021 Completed Product Development
3. Grant 01-May-2019 Completed Product Development
2. Seed Round 06-Jun-2016 $7.2M $7.2M Completed Startup
1. Accelerator/Incubator 26-Nov-2013 Completed Startup
To view Depixus’s complete valuation and funding history, request access »

Depixus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Depixus’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Depixus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel technology intended to offer real-time analysis of individual biomolecular interactions at a massiv
Electronic Equipment and Instruments
Paris, France
63 As of 2024

Munich, Germany
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Depixus Competitors (21)

One of Depixus’s 21 competitors is Dynamic Biosensors, a Formerly VC-backed company based in Munich, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dynamic Biosensors Formerly VC-backed Munich, Germany
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
Roswell Biotechnologies Venture Capital-Backed San Diego, CA
Element Biosciences Venture Capital-Backed San Diego, CA
LUMICKS Venture Capital-Backed Amsterdam, Netherlands
You’re viewing 5 of 21 competitors. Get the full list »

Depixus Patents

  • 44

    Total Documents Applications and Grants

  • Total Patents Families

  • 27

    Granted

  • 16

    Pending

  • Expiring in next 12 mo

Depixus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4481057-A1 Sample preparation methods using modified bases for rapid identification and sequencing Pending 20-Jun-2023
US-20250003011-A1 Sample preparation methods using modified bases for rapid identification and sequencing Pending 20-Jun-2023
US-20230375542-A1 Methods of screening compounds Active 01-Apr-2022
US-12117442-B2 Methods of screening compounds Active 01-Apr-2022
US-20250035624-A1 Methods of screening compounds Pending 01-Apr-2022 G01N33/54373
To view Depixus’s complete patent history, request access »

Depixus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Depixus Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund Minority
Casdin Capital Venture Capital Minority
Lansdowne Partners Hedge Fund Minority
Horizon 2020 Government
Innovate UK Government
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Depixus FAQs

  • When was Depixus founded?

    Depixus was founded in 2012.

  • Where is Depixus headquartered?

    Depixus is headquartered in Paris, France.

  • What is the size of Depixus?

    Depixus has 63 total employees.

  • What industry is Depixus in?

    Depixus’s primary industry is Electronic Equipment and Instruments.

  • Is Depixus a private or public company?

    Depixus is a Private company.

  • What is Depixus’s current revenue?

    The current revenue for Depixus is .

  • How much funding has Depixus raised over time?

    Depixus has raised $42.1M.

  • Who are Depixus’s investors?

    Bpifrance, Casdin Capital, Lansdowne Partners, Horizon 2020, and Innovate UK are 5 of 7 investors who have invested in Depixus.

  • Who are Depixus’s competitors?

    Dynamic Biosensors, Oxford Nanopore Technologies, Roswell Biotechnologies, Element Biosciences, and LUMICKS are some of the 21 competitors of Depixus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »